GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (LSE:AZN) » Definitions » Shiller PE Ratio

AstraZeneca (LSE:AZN) Shiller PE Ratio : 64.80 (As of Apr. 28, 2024)


View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Shiller PE Ratio?

As of today (2024-04-28), AstraZeneca's current share price is £119.88. AstraZeneca's E10 for the quarter that ended in Mar. 2024 was £1.85. AstraZeneca's Shiller PE Ratio for today is 64.80.

The historical rank and industry rank for AstraZeneca's Shiller PE Ratio or its related term are showing as below:

LSE:AZN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.62   Med: 23.49   Max: 75.22
Current: 64.89

During the past years, AstraZeneca's highest Shiller PE Ratio was 75.22. The lowest was 4.62. And the median was 23.49.

LSE:AZN's Shiller PE Ratio is ranked worse than
87.43% of 517 companies
in the Drug Manufacturers industry
Industry Median: 24.4 vs LSE:AZN: 64.89

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2024 was £1.102. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is £1.85 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AstraZeneca Shiller PE Ratio Historical Data

The historical data trend for AstraZeneca's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Shiller PE Ratio Chart

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.82 35.15 52.72 71.22 59.93

AstraZeneca Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.34 66.74 65.79 59.93 57.80

Competitive Comparison of AstraZeneca's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, AstraZeneca's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Shiller PE Ratio falls into.



AstraZeneca Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AstraZeneca's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=119.88/1.85
=64.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.102/130.0000*130.0000
=1.102

Current CPI (Mar. 2024) = 130.0000.

AstraZeneca Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.372 99.800 0.485
201409 0.123 100.000 0.160
201412 -0.160 99.900 -0.208
201503 0.294 99.600 0.384
201506 0.353 100.100 0.458
201509 0.391 100.200 0.507
201512 0.421 100.400 0.545
201603 0.358 100.400 0.464
201606 -0.002 101.000 -0.003
201609 0.609 101.500 0.780
201612 1.161 102.200 1.477
201703 0.340 102.700 0.430
201706 0.297 103.500 0.373
201709 0.405 104.300 0.505
201712 0.768 105.000 0.951
201803 0.193 105.100 0.239
201806 0.203 105.900 0.249
201809 0.260 106.600 0.317
201812 0.648 107.100 0.787
201903 0.357 107.000 0.434
201906 0.071 107.900 0.086
201909 0.186 108.400 0.223
201912 0.183 108.500 0.219
202003 0.477 108.600 0.571
202006 0.463 108.800 0.553
202009 0.378 109.200 0.450
202012 0.580 109.400 0.689
202103 0.851 109.700 1.008
202106 0.299 111.400 0.349
202109 -0.801 112.400 -0.926
202112 -0.165 114.700 -0.187
202203 0.190 116.500 0.212
202206 0.187 120.500 0.202
202209 0.927 122.300 0.985
202212 0.476 125.300 0.494
202303 0.956 126.800 0.980
202306 0.927 129.400 0.931
202309 0.711 130.100 0.710
202312 0.490 130.000 0.490
202403 1.102 130.000 1.102

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AstraZeneca  (LSE:AZN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AstraZeneca Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca (LSE:AZN) Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

AstraZeneca (LSE:AZN) Headlines

From GuruFocus